The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

NCT06033560 · clinicaltrials.gov ↗

UNKNOWN

Status

6000

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Hypoxemic Respiratory Failure

Interventions

DEVICE: High flow nasal oxygen (HFNO, more than 15 L/min)

Sponsor

Amsterdam UMC, location VUmc